Xenetic Biosciences Inc XBIO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 12:05 PM EDT
4.15quote price arrow up+0.30 (+7.79%)
Volume
286
52 week range
2.55 - 5.97
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.85
  • 52 Week High5.97
  • 52 Week High Date09/20/23
  • 52 Week Low2.55
  • 52 Week Low Date05/18/23

Key Stats

  • Market Cap6.394M
  • Shares Out1.54M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.60
  • YTD % Change11.59

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.85
  • 52 Week High5.97
  • 52 Week High Date09/20/23
  • 52 Week Low2.55
  • 52 Week Low Date05/18/23
  • Market Cap6.394M
  • Shares Out1.54M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta2.60
  • YTD % Change11.59

RATIOS/PROFITABILITY

  • EPS (TTM)-2.74
  • P/E (TTM)-1.51
  • Fwd P/E (NTM)-2.14
  • EBITDA (TTM)-4.516M
  • ROE (TTM)-35.28%
  • Revenue (TTM)2.54M
  • Gross Margin (TTM)100.00%
  • Net Margin (TTM)-162.78%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Xenetic Biosciences Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Xenetic Biosciences, Inc. is a biopharmaceutical company. The Company is focused on advancing immune-oncology technologies addressing hard to treat cancers. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer progression. It is focused on advancing the development of its DNase platform toward a first-in-human, multicenter, dose...
Adam Logal
Independent Chairman of the Board
Jeffrey Eisenberg
Chief Executive Officer, Director
James Parslow
Chief Financial Officer, Corporate Secretary
Address
945 Concord St.
Framingham, MA
01701
United States

Top Peers

SYMBOLLASTCHG%CHG
OPGN
OpGen Inc
0.5889-0.0241-3.9315%
SCPX
Scorpius Holdings Inc
0.162+0.002+1.25%
ENSC
Ensysce Biosciences Inc
0.5599+0.0016+0.2866%
ARDS
Aridis Pharmaceuticals Inc
0.0605-0.003-4.7244%
CYCN
Cyclerion Therapeutics Inc
2.77-0.28-9.18%